Drug discovery company PharmEnable has closed a pre-Series A investment round of £6 million to develop the next generation of small molecule drugs. The funding round was led by MP Healthcare Venture Management (MPH), the venture arm of Mitsubishi Tanabe Pharma Group, with additional participation from existing investors including Cambridge Enterprise, the commercialisation arm of … Continue reading Cancer-fighting startup PharmEnable raises £6m